Synthesis and antimycobacterial activity of 2-(Phenylthio) benzoylarylhydrazone Derivatives

Iranian Journal of Pharmaceutical Research

Volumn 10, Issue 4, 2011, Pages 727-731

  Almasirad, Ali ^a   Samiee Sadr, Somayeh ^a   Shafiee, Abbas ^b  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b Tehran University of Medical Sciences   (Iran)

Author keywords

5 Nitrofuran; 5 Nitrothiophen; Antimycobacterial activity; Hydrazones; Mycobacterium tuberculosis

Indexed keywords

2 (PHENYLTHIO)BENZOIC ACID(2 FURYLIDENE)HYDRAZIDE; 2 (PHENYLTHIO)BENZOIC ACID(2 THIENYLIDENE)HYDRAZIDE; 2 (PHENYLTHIO)BENZOIC ACID(4 NITROBENZYLIDENE)HYDRAZIDE; 2 (PHENYLTHIO)BENZOIC ACID(4 PYRIDINYLIDENE)HYDRAZIDE; 2 (PHENYLTHIO)BENZOIC ACID(5 NITRO 2 FURYLIDEN)HYDRAZIDE; 2 (PHENYLTHIO)BENZOIC ACID(5 NITRO 2 THIENYLIDEN)HYDRAZIDE; 2 (PHENYLTHIO)BENZOIC ACID(BENZYLIDENE)HYDRAZIDE; ALDEHYDE; HYDRAZIDE; HYDRAZONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIMYCOBACTERIAL ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CATALYSIS; CHEMICAL STRUCTURE; DRUG INHIBITION; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 84859528464     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Kaufmann SH. Protection against tuberculosis: cytokines, T cells and macrophages. Ann. Rheum. Dis. (2002) 61: 54-58.
2. Chiang CY and Schaaf HS. Management of drug-resistant tuberculosis. Int. J. Tuber. Lung. Dis. (2010) 14: 672-682.
3. Levy SB. Antibiotic resistance-the problem intensifies. Adv. Drug. Delivery. Rev. (2005) 57: 1446-1450.
4. Vessal GH, Afhami SH, Gholami KH, Shafaghi B and Hekmat Yazdi S. Evaluation of antimicrobial resistance among Gram-negative isolates collected from intensive care units and reliability of routine disc susceptibility tests at a teaching hospital in tehran. Iranian J. Pharm. Res. (2006) 5: 89-100.
5. Poole k. Multidrug resistance in Gram-negative bacteria. Curr. Opin. Microbiol. (2001) 4: 500-508.
6. Bhowruth V, Dover LG and Besra GS. Tuberculosis chemotherapy recent developments and future perspectives. In: King FD and Lawton G. (eds.) Progress in Medicinal Chemistry and Management. Elsevier, Oxford (2007) 169-204.
7. Imramovsky A, Vinsova J, Ferriz JM, Dolezal R, Jampilek J, Kaustova J and Kunc F. New antituberculotics originateted from salicylanilides with promising in-vitro activity against atypical mycobacterial strains. Bioorg. Med. Chem. (2008) 17: 3572-3579.
8. Abbasi Nazari M, Kobarfard F, Tabarsie P, Azimi M and Salamzadeh J. Effect of antituberculosis regimen containing ethambutol on serum magnesium level in pulmonary tuberculosis patie. Iranian J. Pharm. Res. (2009) 8: 33-36.
9. Letafat B, Emami S, Aliabadi A, Mohammadhosseini N, Moshafi MH, Asadipour A, Shafiee A and Foroumadi A. Synthesis and in-vitro antibacterial activity of 5-substituted 1-methyl-4-nitro-1H-imidazoles. Arch. Pharm. (2008), 341: 497-501.
10. Cocco MT, Congiu C, Onnis V, Pusceddo MC, Schivo ML and Delogu A. Synthesis and antimycobacterial activity of some isonicotinoylhydrazones. Eur. J. Med. Chem. (1999) 34: 1071-1076.
11. Foroumadi A, Kargar Z, Sakhteman A, Sharifzadeh Z, Feyzmohammadi R, Kazemi M and Shafiee A. Synthesis and antimycobacterial activity of some alkyl [5-(nitroaryl)-1,3,4-thiadiazol-2-ylthio] propionates. Bioorg. Med. Chem. Lett. (2006) 16: 1164-1167.
12. Sriram D, Yogeeswari P and Madhu K. Synthesis and in-vitro and in-vivo antimycobacterial isonicotinoylhydrazones. Bioorg. Med. Chem. Lett. (2005) 15: 4502-4505.
13. Foroumadi A, Soltani F, Jabini R, Moshafi M, Rasnani FM. Antituberculosis agents X. Synthesis and evaluation of in-vitro antituberculosis activity of 2-(5-nitrofuryl)-and 2-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,3,4-thiadiazole derivstives. Arch. Pharm. Res. (2004) 27 (50): 502-506.
14. Herzigova P, Klimesova V, Palat K, Kaustova J, Dahse HM and Mollmann V. Preparation and in-vitro evaluation of 4-benzylsulfanylpyridine-2-carbohydrazides as potential antituberculosis agents. Arch. Pharm. Chem. Life. Sci. (2009) 342: 394-404.
15. Trivedi A, Dodiya D, Surani J, Jarsania S, Mathukiya H, Ravat N and Shah V. Facile one-pot synthesis and antimycobacterial evaluation of pyrazolo[3,4-d]pyrimidines. Arch. Pharm. Chem. Life. Sci. (2008) 341: 435-439.
16. Almasirad A, Vousooghi N, Tabatabai SA, Kebriaeezadeh A and Shafiee A. Synthesis, anticonvulsant and muscle relaxant activities of substituted 1, 3, 4-oxadiazole, 1,3,4-thiadiazole and 1,2,4-triazole. Acta Chim. Slov. (2007) 54: 317-324.
17. Almasirad A, Tajik M, Bakhtiari D, Shafiee A, Abdollahi M, Zamani MJ, Khorasani R and Esmaily H. Synthesis and analgesic activity of N-arylhydrazone derivatives of mefenamic acid. J. Pharm. Pharmaceut. Sci. (2005) 8: 419-425.
18. Almasirad A, Hosseini R, Jalalizadeh H, Rahimi-Moghaddam Z, Abaeian N, Janafrooz M, Abbaspour M, Ziaee V, Dalvandi A and Shafiee A. Synthesis and analgesic activity of 2-phenoxybenzoic acid and N-phenylanthranilic acid hydrazides. Biol. Pharm. Bull. (2006) 29: 1180-1185.
19. Franzblau SG, Witzig RS, Mclaughlin JC, Torres P, Madico G, Hernandez A, Degnan MT, Coo MB, Quenzer VK, Freguson RM and Gilman RH. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the Microplate Almaar Blue Assay. J. Clin. Microbiol. (1998) 36: 362-366.
20. Kaplancikli ZA, Turanzitouni G, Ozdemir A and Teulade JC. Synthesis and antituberculosis activity of new hydrazide derivatives. Arch. Pharm. Chem. Life. Sci. (2008) 341: 721-724.
21. Foroumadi A, Kiani Z and Soltani F. Antituberculosis agents VIII. Synthesis and in-vitro antimycobacterial activity of alkyl α-[5-(5-nitro-2-thienyl)-1,3,4-thiadiazole-2-ylthio] acetates. Il. Farmaco. (2003) 58: 1073-1076.